Lise Munsie

Lise Munsie is currently the Vice President at CCRM, leading a team focused on advancing allogeneic iPSC therapies into manufacturing. With a background in biochemistry and biomedical science, Lise has held various roles in research and development, focusing on pluripotent stem cell therapies and gene editing. In addition to their work in the industry, Lise is also a Director on the board of directors for the Huntington Society of Canada, working towards a world free of Huntington's Disease. Prior to their current position, Lise was a Postdoctoral Fellow at The University of British Columbia, where Lise studied the genetic causes of Parkinson's Disease.